FOXP3 and breast cancer: Studies on Tregs in breast cancer showed that the proportion of blood FOXP3+ CD4+ T cells is increased compared with healthy donors47,48 and that in the tumor high proportions of FOXP3+ CD4+ T cells—detected by immunohistochemistry (IHC)—are associated with a bad prognosis14,15,25,49.